Analysis of Hepatic and Hypothyroidism-related Events in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4-17 years) with focal Seizures

被引：0
|
作者：
Wheless, James [1 ,2 ]
Kothare, Sanjeev V. [3 ]
Grinnell, Todd [4 ]
Cantu, David [4 ]
Li, Yan [4 ]
Costa, Raquel
Magalhaes, Luis M.
Blum, David [4 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Pediat Neurol, Memphis, TN 38163 USA
[2] Le Bonheur Childrens Hosp, Memphis, TN 38163 USA
[3] Cohen Childrens Med Ctr, New York, NY USA
[4] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
NEUROLOGY | 2019年 / 92卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1.5-025
引用
收藏
页数：3
相关论文
共 25 条
  • [21] Associations between seizure severity change and patient characteristics, changes in seizure frequency, and health-related quality of life in patients with focal seizures treated with adjunctive eslicarbazepine acetate: Post hoc analyses of clinical trial results
    Cramer, Joyce A.
    Colman, Sam
    Anastassopoulos, Kathryn P.
    Grinnell, Todd
    Mehta, Darshan
    Williams, G. Rhys
    EPILEPSY & BEHAVIOR, 2020, 112
  • [22] Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial
    Kirkham, Fenella
    Auvin, Stephane
    Moreira, Joana
    Gama, Helena
    Falcao, Amilcar C.
    Rocha, Jose-Francisco
    Soares-da-Silva, Patricio
    EPILEPSY & BEHAVIOR, 2020, 105
  • [23] Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate
    Velez, Fulton F.
    Bond, T. Christopher
    Anastassopoulos, Kathryn P.
    Wang, Xuezhe
    Sousa, Rui
    Blum, David
    Cramer, Joyce A.
    EPILEPSY & BEHAVIOR, 2017, 68 : 203 - 207
  • [24] Incidence of Treatment-Emergent Adverse Events (TEAEs) According to Baseline Antiepileptic Drug (AED) Use: A Pooled Analysis of Data from Phase II/III Trials of Adjunctive Eslicarbazepine Acetate (ESL) in Children
    Wirrell, Elaine
    Loddenkemper, Tobias
    Conry, Joan
    Grinnell, Todd
    Cantu, David
    Gama, Helena
    Rocha, Francisco
    Li, Yan
    Blum, David
    NEUROLOGY, 2018, 90
  • [25] Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (aged 4 to <12 years) with inadequately controlled focal-onset seizures: Japanese subgroup analysis
    Omatsu, Hirowo
    Watanabe, Toshihide
    Kira, Ryutaro
    Ishiba, Kaeko
    Patten, Anna
    Takase, Takao
    Ngo, Leock Y.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2023, 110 : 109 - 116
123